Related Experiment Video

Updated: Mar 20, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K

Patient-derived lung tumoroids reveal determinants of CAR T cell efficacy in solid tumors

Martí Farrera-Sal1, Lukas Ehlen1,2, Michael Schmueck-Henneresse1

  • 1Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Experimental Immunotherapy, Berlin, Germany.

Molecular Therapy. Oncology
|March 19, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Spheroid Killing Assay by CAR T Cells08:19

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

17.5K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K